文献速递抗菌药物管理药物不良反应与药物警戒

药师主导改进青霉素过敏标签患者围手术期抗生素选择

Pharmacist-led improvement in perioperative antibiotic selection for patients with a penicillin allergy label.
PubMed 文献 · Am J Health Syst Pharm · 2023-01-01

该研究评估药师主导的质量改进项目对青霉素过敏标签(PAL)手术患者围手术期抗生素选择的影响。项目将患者风险分层,低风险推荐头孢唑林,高风险避免使用。与干预前422例相比,干预后492例中β-内酰胺类使用率从12.6%升至37.8%(P<0.001),万古霉素和其他二线抗生素使用下降,药物成本降低50%至80%,不良反应无显著变化。

要点

  • 药师风险分层可提高PAL患者β-内酰胺类围手术期预防使用率。
  • 干预后万古霉素和其他二线抗生素使用显著下降。
  • 头孢唑林使用与药物成本降低50%至80%相关。

核心结论

  • 药师主导的抗生素选择算法增加了PAL患者围手术期β-内酰胺类使用,减少了二线抗生素使用和成本,且未显著增加不良反应。

主要发现

  • 干预后β-内酰胺类使用率从12.6%升至37.8%(P<0.001)。
  • 万古霉素使用率从45.5%降至29.5%(P<0.001)。
  • 其他二线抗生素使用率从87.4%降至62.2%(P<0.001)。
  • 干预前无不良反应报告,干预后报告2例潜在不良反应(0% vs 0.4%,P=0.190)。
  • 基于索赔数据的药物成本,接受头孢唑林的患者低50%至80%。

关键数值与推荐

  • 低风险PAL患者推荐头孢唑林;高风险患者避免头孢唑林并使用二线药物。

临床怎么用

  • 临床药师可对PAL患者进行风险分层,低风险者推荐头孢唑林作为围手术期预防用药。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Surgical patients with a penicillin allergy label (PAL) are less likely to receive β-lactams for surgical site infection (SSI) prophylaxis and more likely to receive second-line antibiotics, which may increase the risk of SSI, drug toxicities, and associated costs. We assessed the impact of implementing a pharmacist-led quality improvement project to increase the use of cefazolin as a first-line agent in this population. SUMMARY: After implementation of a pilot project in December 2021, all patients with a PAL and orders for preoperative antibiotics were risk stratified into high- or low-risk categories by a pharmacist. For the low-risk group, cefazolin was recommended. For the high-risk group, cefazolin was avoided and a second-line agent was administered. Our analysis compared 422 preintervention patients (August 15 to November 15, 2021) to 492 postintervention patients (December 15 to March 15, 2022). During the postintervention period, β-lactam usage increased (from 12.6% to 37.8%, P < 0.001), while usage of vancomycin (45.5% vs 29.5%, P < 0.001) and other second-line antibiotics (87.4% vs 62.2%, P < 0.001) declined. There were no adverse reactions reported in the preintervention cohort, with 2 potential adverse reactions reported after the intervention (0% vs 0.4%, P = 0.190). Medication costs based on claims data were 50% to 80% lower for patients receiving cefazolin. CONCLUSION: In our cohort, a pharmacy-led antibiotic selection algorithm for patients with a PAL receiving perioperative antimicrobial prophylaxis resulted in increased use of β-lactam antibiotics, decreased use of second-line antibiotics, and decreased costs without a significant change in the incidence of adverse reactions.

来源:Am J Health Syst Pharm,查看原文。版权归原作者所有。

引用

  1. Stonerock D, Hallo-Carrasco A, Edwards M, et al. Pharmacist-led improvement in perioperative antibiotic selection for patients with a penicillin allergy label. Am J Health Syst Pharm. 2023. PMID: 36680795. doi:10.1093/ajhp/zxad023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。